Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1990 Dec 1;272(2):399–406. doi: 10.1042/bj2720399

Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and D-Phe-Pro-Arg-Ch2Cl.

X J Yang 1, M A Blajchman 1, S Craven 1, L M Smith 1, N Anvari 1, F A Ofosu 1
PMCID: PMC1149713  PMID: 2268268

Abstract

The validity of the hypothesis that Factor Xa activates Factor V in heparinized plasma was examined by establishing the temporal relationships between Factor V proteolysis and prothrombin consumption in plasma. Factor V was cleaved into Factor Va heavy chain (approx. 110 kDa) and an intermediate (approx. 230 kDa) 30 s after CaCl2 was added to contact-activated plasma (CAP). The larger fragment was converted into Factor V activation peptide (approx. 150 kDa) and Factor Va light chain (approx. 80 kDa) 15 s later. Heparin (approx. 0.05 microM) delayed Factor V proteolysis in CAP by at least 30 s. On supplementing CAP with 1 nM-Factor Xa or 1 nM-thrombin, Factor V was activated 15 s later. Heparin prolonged by 15 s and 45 s the time required to demonstrate Factor V activation in CAP supplemented with Factor Xa and thrombin respectively. Factor V was activated 20 s after tissue factor and CaCl2 were added to plasma, both in the absence and in the presence of approx. 0.05 microM-heparin. In contrast, hirudin and D-Phe-Pro-Arg-CH2Cl (two thrombin inhibitors more effective than heparin) delayed Factor V activation in this plasma by at least 30 s. The fragments of Factor V obtained in heparinized CAP suggest thrombin escapes inhibition and contributes to Factor V activation in that plasma. Production of Factor Va heavy chain and the 230 kDa Factor V fragment invariably preceded efficient prothrombin activation. These observations suggest that heparin, hirudin and D-Phe-Pro-Arg-CH2Cl delay Factor V activation by inhibiting thrombin. The availability of Factor Xa markedly moderates the ability of heparin to inhibit Factor V activation.

Full text

PDF
399

Images in this article

400Fig. 1.
on p.400
402Fig. 3.
on p.402
402Fig. 4.
on p.402
403Fig. 5.
on p.403
403Fig. 6.
on p.403
404Fig. 7.
on p.404

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Béguin S., Lindhout T., Hemker H. C. The mode of action of heparin in plasma. Thromb Haemost. 1988 Dec 22;60(3):457–462. [PubMed] [Google Scholar]
  2. Esmon C. T. The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity. J Biol Chem. 1979 Feb 10;254(3):964–973. [PubMed] [Google Scholar]
  3. Fenton J. W., 2nd, Fasco M. J., Stackrow A. B. Human thrombins. Production, evaluation, and properties of alpha-thrombin. J Biol Chem. 1977 Jun 10;252(11):3587–3598. [PubMed] [Google Scholar]
  4. Foster W. B., Nesheim M. E., Mann K. G. The factor Xa-catalyzed activation of factor V. J Biol Chem. 1983 Nov 25;258(22):13970–13977. [PubMed] [Google Scholar]
  5. Hultin M. B. Role of human factor VIII in factor X activation. J Clin Invest. 1982 Apr;69(4):950–958. doi: 10.1172/JCI110534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kettner C., Shaw E. D-Phe-Pro-ArgCH2C1-A selective affinity label for thrombin. Thromb Res. 1979;14(6):969–973. doi: 10.1016/0049-3848(79)90014-8. [DOI] [PubMed] [Google Scholar]
  7. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  8. Mann K. G., Jenny R. J., Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem. 1988;57:915–956. doi: 10.1146/annurev.bi.57.070188.004411. [DOI] [PubMed] [Google Scholar]
  9. Mann K. G., Nesheim M. E., Tracy P. B. Molecular weight of undegraded plasma factor V. Biochemistry. 1981 Jan 6;20(1):28–33. doi: 10.1021/bi00504a005. [DOI] [PubMed] [Google Scholar]
  10. Marlar R. A., Griffin J. H. Alternative pathways of thromboplastin-dependent activation of human factor X in plasma. Ann N Y Acad Sci. 1981;370:325–335. doi: 10.1111/j.1749-6632.1981.tb29745.x. [DOI] [PubMed] [Google Scholar]
  11. Monkovic D. D., Tracy P. B. Activation of human factor V by factor Xa and thrombin. Biochemistry. 1990 Feb 6;29(5):1118–1128. doi: 10.1021/bi00457a004. [DOI] [PubMed] [Google Scholar]
  12. Nesheim M. E., Kettner C., Shaw E., Mann K. G. Cofactor dependence of factor Xa incorporation into the prothrombinase complex. J Biol Chem. 1981 Jul 10;256(13):6537–6540. [PubMed] [Google Scholar]
  13. Nesheim M. E., Mann K. G. Thrombin-catalyzed activation of single chain bovine factor V. J Biol Chem. 1979 Feb 25;254(4):1326–1334. [PubMed] [Google Scholar]
  14. Ofosu F. A., Cerskus A. L., Hirsh J., Smith L. M., Modi G. J., Blajchman M. A. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor. Br J Haematol. 1984 Jun;57(2):229–238. [PubMed] [Google Scholar]
  15. Ofosu F. A., Hirsh J., Esmon C. T., Modi G. J., Smith L. M., Anvari N., Buchanan M. R., Fenton J. W., 2nd, Blajchman M. A. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa. Biochem J. 1989 Jan 1;257(1):143–150. doi: 10.1042/bj2570143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ofosu F. A., Modi G. J., Hirsh J., Buchanan M. R., Blajchman M. A. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides. Ann N Y Acad Sci. 1986;485:41–55. doi: 10.1111/j.1749-6632.1986.tb34566.x. [DOI] [PubMed] [Google Scholar]
  17. Ofosu F. A., Sie P., Modi G. J., Fernandez F., Buchanan M. R., Blajchman M. A., Boneu B., Hirsh J. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin. Biochem J. 1987 Apr 15;243(2):579–588. doi: 10.1042/bj2430579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pieters J., Lindhout T. The limited importance of factor Xa inhibition to the anticoagulant property of heparin in thromboplastin-activated plasma. Blood. 1988 Dec;72(6):2048–2052. [PubMed] [Google Scholar]
  19. Rosing J., Tans G., Govers-Riemslag J. W., Zwaal R. F., Hemker H. C. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem. 1980 Jan 10;255(1):274–283. [PubMed] [Google Scholar]
  20. Smith C. M., Hanahan D. J. The activation of factor V by factor Xa or alpha-chymotrypsin and comparison with thrombin and RVV-V action. An improved factor V isolation procedure. Biochemistry. 1976 May 4;15(9):1830–1838. doi: 10.1021/bi00654a007. [DOI] [PubMed] [Google Scholar]
  21. Stone S. R., Braun P. J., Hofsteenge J. Identification of regions of alpha-thrombin involved in its interaction with hirudin. Biochemistry. 1987 Jul 28;26(15):4617–4624. doi: 10.1021/bi00389a004. [DOI] [PubMed] [Google Scholar]
  22. Suzuki K., Dahlbäck B., Stenflo J. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem. 1982 Jun 10;257(11):6556–6564. [PubMed] [Google Scholar]
  23. Tollefsen D. M., Majerus D. W., Blank M. K. Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. J Biol Chem. 1982 Mar 10;257(5):2162–2169. [PubMed] [Google Scholar]
  24. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Vehar G. A., Davie E. W. Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry. 1980 Feb 5;19(3):401–410. doi: 10.1021/bi00544a001. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES